Home  |  Contact

Cellosaurus Sp2/mIL-6 (CVCL_C561)

[Text version]
Cell line name Sp2/mIL-6
Synonyms Sp2/MIL6; SP2-IL6
Accession CVCL_C561
Resource Identification Initiative To cite this cell line use: Sp2/mIL-6 (RRID:CVCL_C561)
Comments Group: Hybridoma fusion partner cell line.
Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
Transfected with: MGI; MGI:96559; Il6.
Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
Disease Mouse plasma cell myeloma (NCIt: C125417)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c.
Hierarchy Parent: CVCL_2199 (Sp2/0-Ag14)
Children:
CVCL_A8IG (3A1)CVCL_A8IH (3A2 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8II (3A6)
CVCL_A8IJ (3A7)CVCL_A8IK (3B1)CVCL_A8IL (3B3 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IM (3B4 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8IN (3B6 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8IP (3C2 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IQ (3C4 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8IR (3C6 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8IS (3D1 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IT (3D2 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8IU (3D3 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8IV (3D5 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IW (3D7)CVCL_A8IX (3E1 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8IY (3E4 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IZ (3E5)CVCL_A8JA (3F1)CVCL_A8JB (3F2 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JC (3F4 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8JD (3F5 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8JE (3F6 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JF (3G1 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8JG (3G2 [Mouse hybridoma against SARS-CoV-2 spike])CVCL_A8JH (3G6 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JI (3G7)CVCL_A8JJ (3H2)CVCL_A8JK (3H4 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JL (3H6)CVCL_D3TZ (455-2A4)CVCL_A8JM (5A1 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JN (9F2)CVCL_0F32 (IgG-13D3)CVCL_0F33 (IgG-15A6)
Sex of cell Female
Category Cancer cell line
Publications

PubMed=1373425; DOI=10.1016/0022-1759(92)90173-q
Harris J.F., Hawley R.G., Hawley T.S., Crawford-Sharpe G.C.
Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
J. Immunol. Methods 148:199-207(1992)

Cross-references
Cell line collections (Providers) ATCC; CRL-2016
Cell line databases/resources CLO; CLO_0009116
Encyclopedic resources Wikidata; Q54955453
Entry history
Entry creation22-Oct-2012
Last entry update30-Jan-2024
Version number12